Illumina Share Price Today
(NASDAQ: ILMN)

Name: Illumina Share Price Today (NASDAQ: ILMN) - Illumina Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Illumina share price is $132.74 & ₹11,500.59 as on 1 Feb 2025, 2.30 'hrs' IST

$132.74

▲

-0.27

(-0.2%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Illumina share price in Dollar and Rupees. Guide to invest in Illumina stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Illumina, along with analyst recommendations, forecasts, and comprehensive financials.

Illumina share price movements

Today's Low: $131.88
Today's High: $135.66
$132.74
0.65%
Downside
Day's Volatility :2.79%
Upside
2.15%
52 Weeks Low: $100.09
52 Weeks High: $156.66
$132.74
24.6%
Downside
52 Weeks Volatility :36.11%
Upside
15.27%

Illumina (ILMN) Returns

Period	Illumina Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-13.34%	0.3%	0.0%
6 Months	15.19%	-1.5%	0.0%
1 Year	-7.77%	5.0%	0.0%
3 Years	-62.66%	12.3%	-12.8%

Illumina (ILMN) Key Statistics

in dollars & INR

Previous Close	$133.01
Open	$132.94
Today's High	$135.655
Today's Low	$131.875
Market Capitalization	$21.1B
Today's Volume	$1.3M
52 Week High	$156.66
52 Week Low	$100.085
Revenue TTM	$4.4B
EBITDA	$730.0M
Earnings Per Share (EPS)	$-9.97
Profit Margin	-36.11%
Quarterly Earnings Growth YOY	-0.96%
Return On Equity TTM	-39.51%

How to invest in Illumina Stock (ILMN) from India?

It is very easy for Indian residents to invest directly in Illumina from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Illumina stock in both Indian Rupees (INR) and US Dollars (USD). Search for Illumina or ILMN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Illumina or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Illumina shares which would translate to 0.007 fractional shares of Illumina as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Illumina, in just a few clicks!

Returns in Illumina (ILMN) for Indian investors in Rupees

The Illumina stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Illumina investment value today

Current value as on today

₹96,465

Returns

₹3,535

(-3.53%)

Returns from Illumina Stock

₹7,954 (-7.95%)

Dollar Returns

₹4,419 (+4.42%)

Indian investors sentiment towards Illumina (ILMN)

99%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Illumina Stock from India on INDmoney has increased by 99% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Illumina Stock (ILMN Ticker)

Name	Shares Held	Change in Shares	% of Assets
DSP Healthcare Fund Direct Growth	139400	-21944.35	4.78%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	239	0.00	0.17%

Global Institutional Holdings in Illumina

BlackRock Inc
11.69%
Vanguard Group Inc
10.03%
State Street Corp
3.54%
Loomis, Sayles & Company LP
2.74%
Baillie Gifford & Co Limited.
2.28%
Capital World Investors
2.23%

Analyst Recommendation on Illumina

Buy

46%Buy

43%Hold

10%Sell

Based on 30 Wall street analysts offering stock ratings for Illumina(by analysts ranked 0 to 5 stars)

Based on 30 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Illumina Stock (ILMN)

What analysts predicted

Upside of 22.8%

Target:

$163.00

Current:

$132.74

Insights on Illumina Stock (Ticker Symbol: ILMN)

Price Movement
In the last 7 days, ILMN stock has moved down by -2.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 1.11B → 1.08B (in $), with an average decrease of 2.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -1.98B → 705.0M (in $), with an average increase of 382.0% per quarter
ILMN vs A (1 yr)
In the last 1 year, Agilent Technologies Inc. has given 16.4% return, outperforming this stock by 23.4%
ILMN vs A (3 yr)
In the last 3 years, Agilent Technologies Inc. has given 8.7% return, outperforming this stock by 70.6%
Price to Sales
ForILMN every $1 of sales, investors are willing to pay $4.8, whereas for Agilent Technologies Inc., the investors are paying $6.8 for every $1 of sales.

ILMN Illumina Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$3.3B	↑ 21.11%
Net Income	$826.0M	↑ 13.77%
Net Profit Margin	24.78%	↓ 1.6%

	FY19	Y/Y Change
Revenue	$3.5B	↑ 6.3%
Net Income	$1.0B	↑ 21.31%
Net Profit Margin	28.28%	↑ 3.5%

	FY20	Y/Y Change
Revenue	$3.2B	↓ 8.58%
Net Income	$656.0M	↓ 34.53%
Net Profit Margin	20.25%	↓ 8.03%

	FY21	Y/Y Change
Revenue	$4.5B	↑ 39.73%
Net Income	$762.0M	↑ 16.16%
Net Profit Margin	16.84%	↓ 3.41%

	FY22	Y/Y Change
Revenue	$4.6B	↑ 1.28%
Net Income	$-4.4B	↓ 677.95%
Net Profit Margin	-96.07%	↓ 112.91%

	FY23	Y/Y Change
Revenue	$4.5B	↓ 1.75%
Net Income	$-1.2B	↓ 73.64%
Net Profit Margin	-25.78%	↑ 70.29%

	Q2 FY23	Q/Q Change
Revenue	$1.2B	↑ 8.19%
Net Income	$-234.0M	↓ 7900.0%
Net Profit Margin	-19.9%	↓ 20.18%

	Q3 FY23	Q/Q Change
Revenue	$1.1B	↓ 4.85%
Net Income	$-754.0M	↑ 222.22%
Net Profit Margin	-67.38%	↓ 47.48%

	Q4 FY23	Q/Q Change
Revenue	$1.1B	↑ 0.27%
Net Income	$-176.0M	↓ 76.66%
Net Profit Margin	-15.69%	↑ 51.69%

	Q1 FY24	Q/Q Change
Revenue	$1.1B	↓ 4.1%
Net Income	$-126.0M	↓ 28.41%
Net Profit Margin	-11.71%	↑ 3.98%

	Q2 FY24	Q/Q Change
Revenue	$1.1B	↑ 3.35%
Net Income	$-2.0B	↑ 1477.78%
Net Profit Margin	-178.78%	↓ 167.07%

	Q3 FY24	Q/Q Change
Revenue	$1.1B	↓ 2.88%
Net Income	$705.0M	↓ 135.46%
Net Profit Margin	65.28%	↑ 244.06%

	FY18	Y/Y Change
Profit	$2.3B	↑ 25.96%

	FY19	Y/Y Change
Profit	$2.5B	↑ 7.26%

	FY20	Y/Y Change
Profit	$2.2B	↓ 10.7%

	FY21	Y/Y Change
Profit	$3.2B	↑ 43.17%

	FY22	Y/Y Change
Profit	$3.0B	↓ 5.77%

	FY23	Y/Y Change
Profit	$2.7B	↓ 7.67%

	Q2 FY23	Q/Q Change
Profit	$732.0M	↑ 11.76%

	Q3 FY23	Q/Q Change
Profit	$684.0M	↓ 6.56%

	Q4 FY23	Q/Q Change
Profit	$675.0M	↓ 1.32%

	Q1 FY24	Q/Q Change
Profit	$667.0M	↓ 1.19%

	Q2 FY24	Q/Q Change
Profit	$721.0M	↑ 8.1%

	Q3 FY24	Q/Q Change
Profit	$745.0M	↑ 3.33%

	FY18	Y/Y Change
Operating Cash Flow	$1.1B	↑ 30.51%
Investing Cash Flow	$-1.8B	↑ 747.2%
Financing Cash Flow	$594.0M	↓ 437.5%

	FY19	Y/Y Change
Operating Cash Flow	$1.1B	↓ 7.97%
Investing Cash Flow	$745.0M	↓ 141.09%
Financing Cash Flow	$-897.0M	↓ 251.01%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↑ 2.76%
Investing Cash Flow	$-554.0M	↓ 174.36%
Financing Cash Flow	$-766.0M	↓ 14.6%

	FY21	Y/Y Change
Operating Cash Flow	$545.0M	↓ 49.54%
Investing Cash Flow	$-1.1B	↑ 92.96%
Financing Cash Flow	$-51.0M	↓ 93.34%

	FY22	Y/Y Change
Operating Cash Flow	$392.0M	↓ 28.07%
Investing Cash Flow	$-591.0M	↓ 44.71%
Financing Cash Flow	$1000.0M	↓ 2060.78%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$105.0M	↑ 950.0%
Investing Cash Flow	$-37.0M	↓ 33.93%
Financing Cash Flow	$-3.0M	↓ 99.37%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$139.0M	↑ 32.38%
Investing Cash Flow	$-146.0M	↑ 294.59%
Financing Cash Flow	$-707.0M	↑ 23466.67%

Illumina Technicals Summary

Sell

Neutral

Buy

Illumina is currently in a neutral trading position according to technical analysis indicators.

Illumina (ILMN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Illumina Inc.	1.59%	15.19%	-7.77%	-62.66%	-54.67%
Agilent Technologies Inc.	13.45%	12.38%	13.85%	4.95%	84.27%
Idexx Laboratories, Inc.	3.7%	-6.83%	-19.57%	-20.64%	53.75%
Thermo Fisher Scientific, Inc.	16.11%	1.46%	9.95%	0.43%	90.59%
Danaher Corp.	-2.93%	-17.17%	-9.44%	-24.23%	38.56%
Iqvia Holdings Inc.	3.41%	-13.64%	-4.26%	-20.7%	29.97%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Illumina Inc.	91.22	NA	0.62	4.13	-0.4	0.03	NA	13.45
Agilent Technologies Inc.	34.17	34.17	2.48	5.57	0.25	0.08	0.0	20.53
Idexx Laboratories, Inc.	40.5	40.5	4.41	10.69	0.59	0.23	NA	19.72
Thermo Fisher Scientific, Inc.	35.58	35.58	2.21	21.69	0.13	0.05	0.0	128.08
Danaher Corp.	42.37	42.37	2.99	7.76	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.52	26.52	1.05	11.12	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Illumina Inc.	Buy	$21.1B	-54.67%	91.22	-36.11%
Agilent Technologies Inc.	Buy	$43.2B	84.27%	34.17	21.75%
Idexx Laboratories, Inc.	Buy	$34.3B	53.75%	40.5	22.53%
Thermo Fisher Scientific, Inc.	Buy	$217.3B	90.59%	35.58	14.48%
Danaher Corp.	Buy	$160.9B	38.56%	42.37	16.39%
Iqvia Holdings Inc.	Buy	$36.6B	29.97%	26.52	9.17%

About Illumina

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Organization	Illumina
Employees	10590
CEO	Mr. Jacob Thaysen Ph.D.
Industry	Health Technology

Management People of Illumina

Name	Title
Mr. Jacob Thaysen Ph.D.	CEO & Director
Ms. Carissa L. Rollins	Chief Information Officer
Mr. Charles E. Dadswell Esq.	Advisor
Stephanie Campos	President
Mr. Kevin Carl Pegels	Chief of Global Operations
Mr. Scott Ericksen	VP & Chief Accounting Officer
Dr. Steven Barnard Ph.D.	Chief Technology Officer
Ms. Sallilyn Schwartz	Vice President of Investor Relations
Mr. Scott Davies	Interim General Counsel & Secretary
Mr. Jakob Wedel	Chief Strategy & Corporate Development Officer and CEO Chief of Staff

Important FAQs about investing in ILMN Stock from India :

What is Illumina share price today?

Illumina share price today stands at $132.74, Open: $132.94 ; Previous Close: $133.01 ; High: $135.66 ; Low: $131.88 ; 52 Week High: $156.66 ; 52 Week Low: $100.09.

The stock opens at $132.94, after a previous close of $133.01. The stock reached a daily high of $135.66 and a low of $131.88, with a 52-week high of $156.66 and a 52-week low of $100.09.

Can Indians buy Illumina shares?

Yes, Indians can invest in the Illumina (ILMN) from India.

With INDmoney, you can buy Illumina at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Illumina at zero transaction cost.

How can I buy Illumina shares from India?

It is very easy to buy Illumina from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Illumina (ILMN) be purchased?

Yes, you can buy fractional shares of Illumina with INDmoney app.

What are the documents required to start investing in Illumina stocks?

To start investing in Illumina, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.